Spatial Omics Market, by Technology Type (Spatial Proteomics, Spatial Transcriptomics, Spatial Genomics), by Product Type (Instruments, Consumables, Software), by Work Flow (Sample Preparation, Instrumental Analysis, Data Analysis), by Sample Type (FFPE,

Spatial Omics Market, by Technology Type (Spatial Proteomics, Spatial Transcriptomics, Spatial Genomics), by Product Type (Instruments, Consumables, Software), by Work Flow (Sample Preparation, Instrumental Analysis, Data Analysis), by Sample Type (FFPE, Fresh Frozen), by End Use (Academics & Translational Research Institutes, Pharmaceutical & Biotechnology Companies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Spatial omics technologies have emerged during the last few years and have changed the way we understand multicellular biological systems, which includes genomics, transcriptomics, proteomics, and metabolomics.

Conventional proteomics and transcriptomics have provided granular insights into disease proliferation via identification of discrete cell population along with other pathological issues. Moreover, spatial omics methods provide high resolution mapping of expression profiles of cell tissues similar to that provided by mass spectrometry. Ability to retain spatial content of various cells in samples along with their cellular geometry and surrounding extracellular matrix (ECM) is likely to offer spatial omics with an opportunity to explore unexplored signal modalities.

Surge in acceptance of spatial genomics by start-ups and small firms along with its massive use in biomarker identification will drive the market, in addition to this, rise in application of spatial genomics in drug development and medicine discovery will create lucrative avenues for spatial omics industry.

Market Dynamics

The increasing population of cancers, rising research and development activities, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global spatial omics market over the forecast period.

According to American Cancer Society, in the U.S in 2022, about 99,780 new melanomas will be diagnosed (about 57,180 in men and 42,600 in women) and about 7,650 people are expected to die of melanoma (about 5,080 men and 2,570 women).

Key features of the study:

• This report provides in-depth analysis of the global spatial omics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global spatial omics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode Diagnostics, Fluidigm Corporation, IonPath Inc., Millennium Science Pty Ltd, NanoString Technologies, PerkinElmer, Rebus Biosystems, Ultivue Inc., Vizgen Corp, Dovetail Genomics, S2 Genomics, Inc., Seven Bridges Genomics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global spatial omics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global spatial omics market

Detailed Segmentation:

• Global Spatial Omics Market, By Technology Type:
• Spatial Proteomics
• Spatial Transcriptomics
• Spatial Genomics
• Global Spatial Omics Market, By Product Type:
• Instruments
• Consumables
• Software
• Global Spatial Omics Market, By Workflow:
• Sample Preparation
• Instrumental Analysis
• Data Analysis
• Global Spatial Omics Market, By Sample Type:
• FFPE
• Fresh Frozen
• Global Spatial Omics Market, By End User:
• Academics & Translational Research Institutes
• Pharmaceutical & Biotechnology Companies
• Global Spatial Omics Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region
• South Africa
• Central Africa
• North Africa
• Company Profiles
• 10x Genomics.*
• Company Overview
• Material Portfolio
• Financial Performance
• Key Highlights
• Market Strategies
• Akoya Bioscience Inc
• Biognosys AG
• BioSpyder Technologies
• Bio-Techne
• Bruker
• Brooks Automation Inc
• Danaher Corporation
• Diagenode Diagnostics
• Fluidigm Corporation
• IonPath Inc
• Millennium Science Pty Ltd
• NanoString Technologies
• PerkinElmer
• Rebus Biosystems
• Ultivue Inc
• Vizgen Corp
• Dovetail Genomics
• S2 Genomics, Inc
• Seven Bridges Genomics

“*” marked represents similar segmentation in other categories in the respective section.